<?xml version="1.0" encoding="UTF-8"?>
<response>

<lst name="responseHeader">
  <int name="status">0</int>
  <int name="QTime">13</int>
  <lst name="params">
    <str name="echoParams">explicit</str>
    <str name="indent">true</str>
    <str name="file">data-lines/./reut2-019.sgm-552.txt</str>
    <str name="usePOS">true</str>
    <str name="sentences">3</str>
    <str name="wt">xml</str>
    <str name="formula">augNorm_inverse</str>
  </lst>
</lst>
<lst name="analysis">
  <lst name="summary">
    <lst name="stats">
      <lst name="sentences">
        <int name="count">14</int>
      </lst>
      <lst name="terms">
        <int name="count">46</int>
      </lst>
      <lst name="stems">
        <int name="count">29</int>
      </lst>
    </lst>
    <lst name="terms">
      <lst name="term">
        <str name="text">consideration</str>
        <double name="strength">1.0</double>
      </lst>
      <lst name="term">
        <str name="text">medical</str>
        <double name="strength">0.9999999999999998</double>
      </lst>
      <lst name="term">
        <str name="text">pharmaceuticals</str>
        <double name="strength">0.9999999999999998</double>
      </lst>
      <lst name="term">
        <str name="text">merignac</str>
        <double name="strength">0.9999999999999998</double>
      </lst>
      <lst name="term">
        <str name="text">bordeaux</str>
        <double name="strength">0.9999999999999998</double>
      </lst>
    </lst>
    <lst name="sentences">
      <lst name="sentence">
        <str name="text">Degussa said last week it intended to buy 100 pct of the capital of the medical pharmaceuticals group Sarget, based in Merignac near Bordeaux.</str>
        <int name="index">4</int>
        <int name="start">1</int>
        <int name="end">143</int>
        <double name="strength">1.0</double>
        <int name="terms">8</int>
      </lst>
      <lst name="sentence">
        <str name="text">The company said in a statement it would also raise nominal share capital by 20 mln marks in a share swap as part of its planned takeover of French medicine group &lt;Laboratoires Sarget SA&gt;.</str>
        <int name="index">2</int>
        <int name="start">1</int>
        <int name="end">189</int>
        <double name="strength">0.8804811163008677</double>
        <int name="terms">13</int>
      </lst>
      <lst name="sentence">
        <str name="text">Sarget had 1986 sales in France, Belgium, the Netherlands, Spain, Portugal and Italy of 730 mln French francs.</str>
        <int name="index">5</int>
        <int name="start">1</int>
        <int name="end">111</int>
        <double name="strength">0.8728236789356484</double>
        <int name="terms">7</int>
      </lst>
    </lst>
    <lst name="highlighted">
      <lst name="sentence">
        <str name="text">&lt;em&gt;Degussa&lt;/em&gt; said last week it intended to buy 100 pct of the &lt;em&gt;capital&lt;/em&gt; of the &lt;em&gt;medical pharmaceuticals group Sarget,&lt;/em&gt; based in &lt;em&gt;Merignac&lt;/em&gt; near &lt;em&gt;Bordeaux&lt;/em&gt;.</str>
        <int name="index">4</int>
      </lst>
      <lst name="sentence">
        <str name="text">The &lt;em&gt;company&lt;/em&gt; said in a &lt;em&gt;statement&lt;/em&gt; it would also &lt;em&gt;raise nominal share capital&lt;/em&gt; by 20 mln &lt;em&gt;marks&lt;/em&gt; in a &lt;em&gt;share&lt;/em&gt; swap as part of its &lt;em&gt;planned takeover&lt;/em&gt; of &lt;em&gt;French medicine group &lt;/em&gt;&lt;Laboratoires &lt;em&gt;Sarget SA&gt;&lt;/em&gt;.</str>
        <int name="index">2</int>
      </lst>
      <lst name="sentence">
        <str name="text">&lt;em&gt;Sarget&lt;/em&gt; had 1986 &lt;em&gt;sales&lt;/em&gt; in &lt;em&gt;France,&lt;/em&gt; Belgium, the &lt;em&gt;Netherlands, Spain, Portugal&lt;/em&gt; and Italy of 730 mln &lt;em&gt;French francs&lt;/em&gt;.</str>
        <int name="index">5</int>
      </lst>
    </lst>
  </lst>
</lst>
</response>
